Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Royalty Expense

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Royalty Expense

NIAGEN BIOSCIENCE, INC. (NAGE) reported Royalty Expense of $1.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:RoyaltyExpense · last filed 2026-03-04

  • NIAGEN BIOSCIENCE, INC. royalty expense for fiscal 2025 was $1.20M, a 0.00% change from fiscal 2024.
  • NIAGEN BIOSCIENCE, INC. royalty expense for fiscal 2024 was $1.20M, a 42.86% decline from fiscal 2023.
  • NIAGEN BIOSCIENCE, INC. royalty expense for fiscal 2023 was $2.10M, a 5.00% increase from fiscal 2022.
  • NIAGEN BIOSCIENCE, INC. royalty expense for fiscal 2022 was $2.00M, a 11.11% increase from fiscal 2021.
Period endRoyalty Expense 12 monthRoyalty Expense 12 month as first filed
2025-12-31$1.20M
10-K · filed 2026-03-04
2024-12-31$1.20M
10-K · filed 2026-03-04
2023-12-31$2.10M
10-K · filed 2025-03-04
2022-12-31$2.00M
10-K · filed 2024-03-06
2021-12-31$1.80M
10-K · filed 2023-03-08
2020-12-31$1.90M
10-K · filed 2022-03-14
2019-12-31$2.70M
10-K · filed 2021-03-12
2018-12-31$1.70M
10-K · filed 2019-03-07
2017-12-30$1.00M
10-K · filed 2019-03-07
$992.00K
10-K · filed 2018-03-15
2016-12-31$773.00K
10-K · filed 2018-03-15
2016-01-02$583.00K
10-K · filed 2018-03-15
2015-01-03$323.00K
10-K · filed 2017-03-16
2013-12-28$111.00K
10-K · filed 2016-03-17
2012-12-29$75.00K
10-K · filed 2014-03-27
$74.80K
10-K · filed 2013-03-29
2011-12-31$37.05K
10-K · filed 2013-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87